Pulse Biosciences, Inc.
PLSE
Rangering i aksjer
#4273
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Aksjekurs
$51.39
Sist synkronisert: 2026-10-21
Markedsverdi
$3.67B
Endring (1 dag)
1.09%
Endring (1 år)
197.94%
Land
US
Handel Pulse Biosciences, Inc. (PLSE)
Kategori
Healthcare
Utbytteavkastning for Pulse Biosciences, Inc. (PLSE)
Pulse Biosciences, Inc. (aksjesymbol: PLSE) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Pulse Biosciences, Inc. (PLSE) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
| År | Utbytteavkastning | Endre |
|---|---|---|
| Ikke nok data for de angitte datoene. | ||
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
| Selskap | Utbytteavkastning | Land |
|---|---|---|
| 0.00% |
US
|
|
| 2.70% |
FR
|
|
| 0.00% |
JP
|
|
| 2.10% |
US
|
|
| 0.00% |
CH
|
